Strata Critical Medical (SRTA) Receivables (2020 - 2026)

Strata Critical Medical has disclosed Receivables across 7 years of filings, most recently posting $39.6 million for Q1 2026.

• In Q1 2026, Receivables rose 78.97% year-over-year to $39.6 million; the TTM figure through Mar 2026 stood at $39.6 million (up 78.97% YoY), while the FY2025 annual figure was $40.0 million, up 101.58% from the prior year.
• Receivables fell to $39.6 million in Q1 2026, from $40.0 million in the prior quarter.
• Over the last five years, Receivables for SRTA reached as high as $40.0 million in Q4 2025 and fell as low as $6.0 million in Q1 2022.
• The 5-year median for Receivables is $22.1 million (2025), against an average of $22.5 million.
• Annual changes were most pronounced in 2022 — Receivables soared 464.95% — and 2025, when it retreated 6.04%.
• A 5-year view of Receivables shows it stood at $10.9 million in 2022, then surged by 93.11% to $21.0 million in 2023, then dropped by 5.63% to $19.8 million in 2024, then jumped by 101.58% to $40.0 million in 2025, then slipped by 0.89% to $39.6 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $39.6 million, $40.0 million, and $37.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.